Semaglutide vs Tirzepatide (Ozempic vs Mounjaro): How They Differ | Dr. Manuj Sondhi

Semaglutide vs Tirzepatide (Ozempic vs Mounjaro): How They Differ

An educational guide by Dr. Manuj Sondhi, MRCP (UK) | Nirvana Clinic, Greater Noida Medically reviewed by Dr. Manuj Sondhi, MRCP (UK), MD, DNB — Consultant Physician & Diabetologist, Nirvana Clinic, Greater Noida · Last updated: 10 July 2026Part of the complete GLP-1 Therapy Guide for India →

📣 As quoted in CNA Dr. Manuj Sondhi was interviewed by Channel NewsAsia on India's changing weight-loss medicine landscape and the importance of safe, supervised use. Read more →

GLP-1-based medicines have changed how doctors approach metabolic care and weight management. Two molecules are most often discussed — semaglutide (known by the brand name Ozempic, and Wegovy for weight management) and tirzepatide (known by the brand name Mounjaro). Patients frequently ask how they differ and which might be appropriate.

This guide explains the difference in plain language. It is for general education only — it is not medical advice, an advertisement, or a recommendation of any product, and whether either medicine is suitable for you can only be decided by a physician after an individual assessment.

What Is Semaglutide (Ozempic)?

Semaglutide is a once-weekly injectable medicine originally developed for type-2 diabetes. It works by mimicking the GLP-1 hormone, which helps regulate appetite, slows digestion, and improves insulin sensitivity. In India, the brand Ozempic is approved for type-2 diabetes; semaglutide for chronic weight management is marketed as Wegovy.

In clinical use, semaglutide can reduce appetite and support gradual, sustainable weight reduction when combined with lifestyle changes.

What Is Tirzepatide (Mounjaro)?

Tirzepatide is a newer injectable medicine that acts on two metabolic pathways — GLP-1 and GIP receptors. This dual action can produce stronger appetite regulation and metabolic effects than single-hormone medicines. It is known by the brand name Mounjaro and does not yet have an Indian generic.

Studies suggest tirzepatide may result in greater average weight reduction because it influences satiety through more than one physiological pathway.

Semaglutide vs Tirzepatide — Key Differences

Feature Semaglutide (Ozempic / Wegovy) Tirzepatide (Mounjaro)
Active compound Semaglutide Tirzepatide
Mechanism GLP-1 only GLP-1 + GIP (dual action)
Average weight change (trial-based, qualitative) Substantial Greatest average in trials
Approved use in India Type-2 diabetes (Wegovy brand for weight management) As per its approved label

Figures described qualitatively; effects are trial averages and vary between individuals. This is not a recommendation of one medicine over another.

Supervised, Safe Care at Nirvana Clinic

Dr. Manuj Sondhi (MRCP UK) provides medically supervised metabolic care at our Sun Twilight Mall clinic, including:

  • ✅ Clinical suitability first — deciding whether a GLP-1 medicine is appropriate at all.
  • ✅ Personalised titration — escalating doses slowly to reduce nausea.
  • ✅ Lab monitoring — regular checks of kidney and pancreatic health.
  • ✅ Muscle preservation — nutrition plans to protect lean mass during weight loss.

Mounjaro vs Wegovy — Frequently Asked Questions

QIs Mounjaro or Wegovy "better" for weight loss?▼
There is no single winner. In head-to-head trial data, tirzepatide (Mounjaro) produced a greater average weight reduction, while semaglutide (Wegovy) has established cardiovascular outcome data. Trial averages do not predict any individual's result, and the more suitable medicine depends on the whole clinical picture — not weight loss alone. The choice is made with a physician after assessment.
QWhat is the difference between Mounjaro and Wegovy?▼
Mounjaro contains tirzepatide and acts on two receptors (GIP and GLP-1); Wegovy contains semaglutide and acts on the GLP-1 receptor. Both are once-weekly injections. In India, Wegovy is approved for chronic weight management and Mounjaro for type-2 diabetes. Both are prescription-only medicines and are not suitable for everyone.
QWhich is more affordable, Mounjaro or Wegovy?▼
Cost varies by molecule, brand, dose, pharmacy and over time. Semaglutide is available under more than one brand and as DCGI-approved generics; tirzepatide is currently a single brand. Cost should not be the main basis for a medical decision, and is best confirmed with your physician or a licensed pharmacy. This page does not provide drug prices.
QWhere can I get a supervised GLP-1 assessment in Greater Noida?▼
Dr. Manuj Sondhi (MRCP UK) at Nirvana Clinic, Sun Twilight Mall, opposite Delta 1 Metro Station, Greater Noida, provides supervised metabolic assessment and treatment where clinically appropriate. Call or WhatsApp +91 8800262767 to book a consultation.

Related Reading

📍 Location & Booking

Nirvana Clinic
Shop GF-93, Ground Floor, Sun Twilight Mall,
(Opposite Delta 1 Metro Station), Greater Noida, UP 201308

📞 Call/WhatsApp: +91 88002 62767

Educational & medical disclaimer: This article is for general educational and informational purposes only. It does not constitute medical advice, a prescription, an advertisement, or an endorsement of any medicine, brand, or manufacturer. Semaglutide and tirzepatide are prescription-only medicines that are not suitable for everyone and should be started, changed, or stopped only by a registered medical practitioner after an individual assessment. In India, Ozempic is approved for type-2 diabetes; semaglutide for weight management is marketed as Wegovy. Brand names are included solely for patient identification and do not imply that any product is sold, stocked, recommended, or supplied by Nirvana Clinic. No drug prices are provided here; for current pricing, consult your physician or a licensed pharmacy. Always consult a qualified doctor before starting, stopping, or changing any medication.